Clinical Trial Detail

NCT ID NCT01443481
Title Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

Advanced Solid Tumor

Therapies

Dovitinib

Age Groups: adult senior

No variant requirements are available.